BullFrog AI to Participate in H.C. Wainwright Investment Conference
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a leading company in AI-driven drug discovery, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. This important event provides a valuable opportunity for companies and investors to connect and is taking place in a major city.
Accessing Live and Archived Webcasts
Participants and interested investors can view both live and archived webcasts of the event on the company’s investor relations website. The presentation by Vin Singh, the Chief Executive Officer of BullFrog AI, will be available on demand starting September 9, 2024.
About BullFrog AI
BullFrog AI is dedicated to leveraging Artificial Intelligence and machine learning to drive innovative drug discovery and development. By partnering with top research institutions, the company employs causal AI along with its proprietary bfLEAP™ platform. This distinctive approach enables them to analyze intricate biological data effectively, with the goal of streamlining the development of therapeutics and minimizing failure rates in clinical trials.
Groundbreaking Solutions
The bfLEAP™ platform empowers BullFrog AI to analyze data and predict outcomes that traditional methods may miss. This advanced capability has the potential to significantly improve the drug development process, leading to more successful clinical trials and better patient outcomes.
Dedication to Progress
With a strong commitment to advancing healthcare solutions, BullFrog AI is continuously pushing the limits in drug discovery. The incorporation of state-of-the-art technology into pharmaceutical development is essential for keeping pace with modern trends and demands in the healthcare sector.
Contact Information
For further inquiries, investors can contact Dave Gentry at RedChip Companies, Inc. via email or phone. Here are the contact details:
Contact:
Investors
Dave Gentry
RedChip Companies, Inc.
Email: BFRG@redchip.com
Phone: 1-407-644-4256
Frequently Asked Questions
What is the purpose of BullFrog AI's participation in the conference?
The conference serves to highlight BullFrog AI's progress in AI-driven drug discovery and to foster connections with investors.
Who will present on behalf of BullFrog AI?
Vin Singh, the Chief Executive Officer of BullFrog AI, will be the presenter at the conference.
When will the presentation be available to view?
The on-demand presentation will be accessible starting September 9, 2024, at 7:00 AM ET.
What technology does BullFrog AI use in its research?
BullFrog AI employs Artificial Intelligence and machine learning, particularly through its bfLEAP™ platform, to analyze complex biological data.
How can investors contact BullFrog AI for more information?
Investors can reach out to Dave Gentry via email at BFRG@redchip.com or call 1-407-644-4256 for any inquiries.
